Iris Arts
La GroLa Gro‘s group is well-equipped to handle the broad range of intricate patent issues, including acting for its sector-spanning clients in infringement and invalidity proceedings before the UPC and the Dutch courts. Benjamin Niemeijer heads up the practice alongside Marleen van den Horst; both team leads harness standout expertise in pharma and life sciences-related matters in particular. ’Exceptional lawyer’ Iris Arts is also a noteworthy name.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team is very knowledgeable, and very importantly, great to work with and very reliable.’
‘Very knowledgeable, innovative and show strong, strategic and tactical thinking capabilities. New areas within the legal field are approached in an impressive manner.’
‘Benjamin Niemeijer and Vivian Heijnen show brilliant strategic, out-of-the-box thinking which has led us to far better results than we anticipated.'
'They think well ahead, not losing sight of the human touch.’
‘This practice is unique due to its highly knowledgeable people. Their communication skills and thoroughness made every step of the process clear and concise.’
‘Marleen van den Horst was very knowledgeable and clear. Her communication skills are beyond perfect. Iris Arts was also an exceptional lawyer who was very concise and very thorough with her reviews. Both were amazing professionals who were able to help us out without issue.’
‘The team has extensive knowledge of patent law and SPCs with innovative strategies.’
‘Marleen van den Horst is a key name in the Netherlands' patent practice with an extensive knowledge, and she is always available to solve clients' specific problems.’
Key clients
- Oldelft Ultrasound
- Stada Arzneimittel AG
- Adalvo
- Rollepaal (RPF)
- Amgen
- FocusCare
- OrthoApnea
- Insud Pharma
- InterDigital
- Leiden University Medical Center
- T. Stolze Installatietechniek
- Vivisol B
- NecstGen
Work highlights
- Represent OrthoApnea and Vivisol B in infringement proceedings to enforce a patent before the UPC.
- Represented Insud Pharma successfully in proceedings against Galenicum to invalidate a pharmaceutical patent.
- Initiated proceedings to invalidate the Dutch part of EP 165 of Alexion, a patent protecting the use of eculizumab, a biologic, to treat various orphan diseases, like aHUS.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Benjamin Niemeijer, Marleen van den Horst